Journals / Türk Oftalmoloji Dergisi / 2018 / Cilt: 48 - Sayı: 4

Optic Neuropathy and Macular Ischemia Associated with Neurosarcoidosis: A Case Report

Pages
202–205
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, early diagnosis and timely treatment of neurosarcoidosis are importantfor favorable visual outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, we present a case of bilateral optic neuropathy and macular ischemia in the right eye associated with neurosarcoidosis.A 26-year-old woman presented to our clinic with complaints of bilateral blurred vision.
📊
Key Findings & Data:She also reported complaintsof fever, weakness, sweating, arthralgia, and headache for 2 months.
💡
Conclusion & Impact:Furthermore, early diagnosis and timely treatment of neurosarcoidosis are importantfor favorable visual outcomes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, we present a case of bilateral optic neuropathy and macular ischemia in the right eye associated with neurosarcoidosis.A 26-year-old woman presented to our clinic with complaints of bilateral blurred vision. Bilateral granulomatous anterior uveitis,vitritis, optic neuropathy, and macular ischemia were detected in the right eye in slit-lamp examination. She also reported complaintsof fever, weakness, sweating, arthralgia, and headache for 2 months. She was referred to the pulmonary diseases unit of our hospitaldue to hilar lymphadenopathy seen in her chest x-ray, and biopsies were taken for diagnostic purposes. Histological analysis of themediastinal lymph node biopsies revealed chronic, non-caseating, granulomatous inflammation. Furthermore, the patient was referredto a neurologist due to concomitant complaint of intense headaches. She was diagnosed with neurosarcoidosis supported by findingson cranial magnetic resonance imaging and lumbar puncture. She received a 3-day course of high-dose (1 g/day) intravenous steroidtreatment (methylprednisolone) followed by a tapering dose of oral prednisone. The patient began receiving oral methotrexate 15 mg/week as a steroid-sparing agent. Significant improvement in neurological and ophthalmological symptoms occurred in the first week oftreatment. In this case report, we emphasized that neurosarcoidosis should be included in the differential diagnosis of patients with bothbilateral optic neuropathy and macular ischemia. Furthermore, early diagnosis and timely treatment of neurosarcoidosis are importantfor favorable visual outcomes.

🔖

Cite This Article

KILIÇ, A. K., CÖMERT, S. Ş., ARSAN, A. K., TANYILDIZ, B., TEZCAN, M. E., DOĞAN, G., KAYMAK, N. Z. (2022). Optic Neuropathy and Macular Ischemia Associated with Neurosarcoidosis: A Case Report. Türk Oftalmoloji Dergisi, Cilt: 48 - Sayı: 4, 202–205. https://ajindex.com/articles/634633

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S. Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology. 2017;89:2092-2100.
  2. Gelwan MJ, Kellen RI, Burde RM, Kupersmith MJ. Sarcoidosis of the anterior visual pathway: successes and failures. J Neurol Neurosurg Psychiatry. 1988;51:1473-1480.
  3. Baughman RP, Lower EE. Treatment of Sarcoidosis. Clin Rev Allergy Immunol. 2015;49:79-92.
  4. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D. Central nervous system sarcoidosis--diagnosis and management. QJM. 1999;92:103-117.
  5. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med. 1997;157:1864-1868.
  6. Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29:119-127.
  7. Talat L, Lightman S, Tomkins-Netzer O. Ischemic retinal vasculitis and its management. J Ophthalmol. 2014;2014:197675. Yu S, Yannuzzi LA. Bilateral perifoveal macular ischemia in sarcoidosis. Retin Cases Brief Rep. 2014;8:212-214.
  8. Kidd DP, Burton BJ, Graham EM, Plant GT. Optic neuropathy associated with systemic sarcoidosis. Neurol Neuroimmunol Neuroinflamm. 2016;3:e270. Turner RG, James DG, Friedmann AI, Vijendram M, Davies JP. Neuroophthalmic sarcoidosis. Br J Ophthalmol. 1975;59:657-663.
  9. Rao DA, Dellaripa PF. Extrapulmonary manifestations of sarcoidosis. Rheum Dis Clin North Am. 2013;39:277-297.
  10. Menezo V, Lobo A, Yeo TK, du Bois RM, Lightman S. Ocular features in neurosarcoidosis. Ocul Immunol Inflamm. 2009;17:170-178. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336-345.
  11. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909-917.
  12. Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86:648-655. Karma A. Ophthalmic changes in sarcoidosis. Acta Ophthalmol Suppl. 1979:1-94.
  13. Bradley D, Baughman RP, Raymond L, Kaufman AH. Ocular manifestations of sarcoidosis. Semin Respir Crit Care Med. 2002;23:543-548. Costabel